Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]

Mostrar otras versiones (1)

BACKGROUND: Although serotonin reuptake inhibitors are effective in the treatment of OCD, many patients fail to respond to these agents. Growing evidence from open-label and placebo-controlled trials suggests a role for augmentation of SRIs with atypical antipsychotics in OCD. Quetiapine is generall...

Descripción completa

Detalles Bibliográficos
Autores principales: Carey, Paul D, Vythilingum, Bavanisha, Seedat, Soraya, Muller, Jacqueline E, van Ameringen, Michael, Stein, Dan J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547907/
https://www.ncbi.nlm.nih.gov/pubmed/15667657
http://dx.doi.org/10.1186/1471-244X-5-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC547907/
https://www.ncbi.nlm.nih.gov/pubmed/15667657
http://dx.doi.org/10.1186/1471-244X-5-5

Ejemplares similares